Pace Corporate

Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dean Bornilla has been named Head of Commercial reporting to Dawn Von Rohr, President, Pace® Life […]

Pace Life Sciences LLC, a central laboratory and contract development and manufacturing organization, received an “overall positive review” from the Food & Drug Administration (FDA) after a comprehensive three-day inspection of its San Germán laboratory’s quality systems and data delivery processes. Read more here.

Long-standing reputation for robust quality is confirmed as company enters 2024  SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life Sciences, LLC, a full-service FDA-registered central laboratory and contract development and manufacturing organization (CDMO) announced the receipt of an overall positive review from The Food & Drug Administration (FDA), following a three-day general inspection of

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO), announced today that it has acquired the Lebanon, New Jersey laboratory facility (formerly Whitehouse Analytical Laboratories) from Curia, a global contract research, development, and manufacturing (CDMO) company.

Von Rohr brings over 25 years of experience to company Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dawn Von Rohr has been named Division President. Von Rohr will be responsible for driving growth and continued innovations within the Pace®